检验医学 ›› 2012, Vol. 27 ›› Issue (1): 15-17.

• 临床检验与血液学检验论著 • 上一篇    下一篇

浆膜腔脱落细胞学检查与肿瘤标志物水平相关性探讨

  

  1. 1. 山东威海市立医院, 山东 威海 264200; 2. 第二军医大学附属长海医院实验诊断科,  上海 200433; 3. 温州医学院第二附属医院呼吸内科, 浙江 温州 325000
  • 收稿日期:2011-02-17 出版日期:2012-01-20 发布日期:2012-01-20
  • 作者简介:高胜海,男,1973年生,学士,主治医师,主要从事细胞学诊断工作。

Research on the correlation of serous membrane cavity exfoliative cytology examination and tumor marker levels

  1. 1. Weihai Hospital of Shandong Province, Shandong Weihai 264200, China; 2. Department of Diagnosis, Changhai Hospital, Second Military Medical University, Shanghai 200433, China; 3.Department of Respiratory, the Second Affiliated Hospital of Wenzhou Medical College, Zhejiang Wenzhou 325000, China
  • Received:2011-02-17 Online:2012-01-20 Published:2012-01-20

摘要: 目的  探讨在判断恶性肿瘤侵犯浆膜时脱落细胞学检查与肿瘤标志物水平的关系。方法  选择158例有明确恶性肿瘤病史的患者,依据细胞学检查结果分为检出恶性细胞组和未检出恶性细胞组,并对其血清及浆膜腔积液肿瘤标志物水平进行检测分析。结果  检出恶性细胞组浆膜腔积液癌胚抗原(CEA)、糖类抗原199(CA199)和糖类抗原125(CA125)水平分别为294.85(6.03~1 000.00) μg/L、367.00(8.82~1 000.00) kU/L、3 435.00(922.20~5 000.00) kU/L,血清分别为9.98(0.48~1 000.00) μg/L、23.76(0.66~1 000.00) kU/L、90.55(47.21~1 796.00) kU/L,二者比较差异有统计学意义(P均<0.05);未检出恶性细胞组浆膜腔积液CEA、CA199和CA125水平分别为1.67(0.20~373.08) μg/L、13.13(4.34~725.10) kU/L、11.23(6.83~  172.50) kU/L,血清分别为2.69(0.20~110.90) μg/L、31.22(6.07~1 000.00) kU/L、19.32(17.20~  491.10) kU/L,二者比较差异无统计学意义(P均>0.05);检出恶性细胞组与未检出恶性细胞组浆膜腔积液CEA、CA199和CA125水平比较差异有统计学意义(P均<0.01)。检出恶性细胞组中有核细胞分类淋巴细胞>50%者占61.4%(70/114),巨噬细胞>25%者占42.1%(48/114)。结论  恶性肿瘤侵犯浆膜可引起浆膜腔积液肿瘤标志物水平增高及淋巴细胞和巨噬细胞的聚集。

关键词: 浆膜腔积液, 脱落细胞学, 肿瘤标志物

Abstract: Objective To investigate the relationship between the detection results of exfoliative cytology and tumor markers when serous membranes were encroached by malignant tumor cells.   Methods An analysis was performed on the results of exfoliative cytology examination and tumor marker levels in serum and serous membrane cavity effusion among 158 patients with definite history of malignant tumors. The patients were classified into 2 groups according to the positive or negtive detection of tumor cells.  Results Carcinoembryonic antigen (CEA), carbohydrate antigen 199 (  CA199) and carbohydrate antigen 125 (CA125) levels were significantly higher in serous membrane cavity effusion [  294.85(6.031 000.00)μg/L, 367.00(8.821 000.00) kU/L and 3 435.00(922.20~5 000.00) kU/L] than those in sera [9.98(0.481 000.00)μg/L, 23.76(0.661 000.00) kU/L and   90.55(47.211 796.00) kU/L] in patients with malignant tumor cell group (P<0.05). There was no statistical significance in patients without malignant tumor cell group [1.67(0.20373.08)μg/L, 13.13(4.34725.10) kU/L and 11.23(6.83172.50) kU/L in serous membrane cavity effusion; 2.69(0.20110.90) μg/L, 31.22(6.701 000.00) kU/L and 19.32(17.20491.10) kU/L in sera, P>0.05]. A statistical significance of CEA, CA199 and CA125 levels were further disclosed between the patients with and without malignant tumor cells in their serous membrane cavity effusions (P<0.01). As concern to the classification of nucleated cells in patients with malignant tumor cell group, the patients with >50% lymphocytes accounted for 61.4% (70/114), while the patients with >25% macrophages accounted for 42.1% (48/114). Conclusions The infiltration of malignant tumor cells on serous membrane cavity membrane induces the increasing levels of tumor markers and aggregation of lymphocytes and macrophages in the serous membrane cavity effusion. 

Key words: Serous membrane cavity effusion, Exfoliative cytology, Tumor marker